Shelbie Reed
Physician Assistant · Plano, TXNPI 1609226786
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,329 and has fallen 95.2% since, to $64 in 2024.
Across 167 payments — averaging $14.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$427
- Novo Nordisk$342
- AbbVie$190
- Biohaven Pharmaceuticals, Inc.$144
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$124
- Genentech USA, Inc.$102
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,416100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 44 | $427 |
| Novo Nordisk | 25 | $342 |
| AbbVie | 10 | $190 |
| Biohaven Pharmaceuticals, Inc. | 9 | $144 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $124 |
| Genentech USA, Inc. | 6 | $102 |
| Merck | 6 | $101 |
| Amarin Pharma, Inc. | 6 | $99 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $98 |
| Boehringer Ingelheim | 5 | $93 |
| AstraZeneca | 6 | $84 |
| Novartis | 4 | $60 |
| Pfizer | 2 | $53 |
| Lilly USA, LLC | 4 | $53 |
| Astellas Pharma US Inc | 3 | $50 |
| Sunovion Pharmaceuticals Inc. | 3 | $46 |
| GSK | 3 | $44 |
| Currax Pharmaceuticals LLC | 3 | $42 |
| Esperion Therapeutics, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $35 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Arbor Pharmaceuticals, Inc. | 2 | $31 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Vivus LLC | 1 | $15 |
| Medtronic | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Bayer | 1 | $14 |
| Abbott | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $13 |
How this compares
$2,416 in reported general payments places this provider in the 80th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Plano
- Jaime RomanPlano$338K
- Sara FreemanPlano$57K
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Michael WhiteDallas$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.